STOCK TITAN
  1. Home
  2. Sec-filings
  3. DHR
  4. [Form 4] DANAHER CORP /DE/ Insider Trading Activity

Danaher Corp (NYSE: DHR) awards 92,138 stock options to Chief Legal Officer

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Danaher Corporation granted SVP-Chief Legal Officer Jonathan Leiken employee stock options covering 92,138 shares of Common Stock at an exercise price of $194.78 per share. These options expire on August 4, 2036. According to the grant terms, fifty percent of the options become exercisable on each of the fourth and fifth anniversaries of the August 4, 2026 grant date. Following this award, Leiken directly holds derivative securities representing 92,138 underlying shares.

Positive

  • None.

Negative

  • None.
Insider Leiken Jonathan
Role SVP-Chief Legal Officer
Type Security Shares Price Value
Grant/Award Employee stock option (right to buy) F1, F2 92,138 $0.00 $0.00
Holdings After Transaction: Employee stock option (right to buy) — 92,138 shares (Direct)
Footnotes (2)
  1. F1. On the date indicated, Danaher Corporation granted the reporting person employee stock options in the indicated amount in connection with the Issuer's Long-Term Growth Program, as previously reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 3, 2026.
  2. F2. Fifty percent of the options granted become exercisable on each of the fourth and fifth anniversaries of the grant date, which is August 4, 2026.
Options Granted 92,138 options Employee stock option grant to SVP-Chief Legal Officer Jonathan Leiken
Exercise Price $194.78 per share Exercise price of the employee stock options
Underlying Shares 92,138 shares Common Stock underlying the employee stock options
Option Expiration Date August 4, 2036 Expiration date of the employee stock options
Grant Date August 4, 2026 Grant date for vesting schedule reference
Vesting Pattern 50% on 4th and 5th anniversaries Fifty percent of options vest on each of the fourth and fifth anniversaries of the grant date
Employee stock option (right to buy) financial
"security_title: Employee stock option (right to buy)"
Long-Term Growth Program financial
"in connection with the Issuer's Long-Term Growth Program"
underlying security shares financial
"underlying_security_shares: 92138.0000"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Danaher (DHR) report for Jonathan Leiken?
Danaher reported that Jonathan Leiken, SVP-Chief Legal Officer, received an award of 92,138 employee stock options for Common Stock, granted in connection with Danaher’s Long-Term Growth Program.

What is the exercise price of Jonathan Leiken’s new Danaher (DHR) stock options?
The employee stock options granted to Jonathan Leiken have an exercise price of $194.78 per share, meaning he may purchase Danaher Common Stock at that price once the options vest and are exercisable.

When do Jonathan Leiken’s Danaher (DHR) stock options vest?
The grant vests in two equal parts: 50% of the options become exercisable on the fourth anniversary of the August 4, 2026 grant date, and the remaining 50% on the fifth anniversary.

When do Jonathan Leiken’s Danaher (DHR) stock options expire?
The employee stock options granted to Jonathan Leiken expire on August 4, 2036. After that expiration date, any unexercised options will no longer be exercisable for Danaher Common Stock.

How many Danaher (DHR) derivative securities does Jonathan Leiken hold after this grant?
After the reported award, Jonathan Leiken directly holds derivative securities representing 92,138 underlying shares of Danaher Common Stock, all from this single employee stock option grant.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Leiken Jonathan
(Last)(First)(Middle)
2200 PENNSYLVANIA AVE NW
SUITE 800W
(Street)
WASHINGTON DISTRICT OF COLUMBIA 20037
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
DANAHER CORP /DE/ [ DHR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP-Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee stock option (right to buy)$194.7808/04/2026A(1)92,138 (2)08/04/2036Common Stock92,138$092,138D
Explanation of Responses:
1. On the date indicated, Danaher Corporation granted the reporting person employee stock options in the indicated amount in connection with the Issuer's Long-Term Growth Program, as previously reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 3, 2026.
2. Fifty percent of the options granted become exercisable on each of the fourth and fifth anniversaries of the grant date, which is August 4, 2026.
Remarks:
/s/ James F. O'Reilly, attorney-in-fact for Jonathan Leiken08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR